Getting Blenrep (Belantamab Mafodotin) Covered by Humana in Virginia: Complete Guide to Access, Appeals, and Clinical Trial Options
Answer Box: Quick Path to Blenrep Access in Virginia
Blenrep (belantamab mafodotin) is currently unavailable for commercial coverage in the U.S. as GSK resubmits for FDA approval (decision expected October 23, 2025). Virginia patients with Humana can access Blenrep only through:
1. Clinical trials - Contact your oncologist about